1961 - Royal Medico-Psychological Association - Hallucinogenic Drugs and their Psychotherapeutic Use.pdf

(4813 KB) Pobierz
Proceedings of the
Royal Medico-Psychological Association
HALLUCINOGENI
C
DRUG
S
AND THEIR
PSYCHOTHERAPEUTIC
US
E
Edited
RICHARD CROCKET, R. A. SANDISON
AND
ALEXANDER WALK
by
LONDON
H. K. LEWIS & Co. Ltd.
808380591.023.png 808380591.024.png 808380591.025.png 808380591.026.png 808380591.001.png
 
808380591.002.png 808380591.003.png 808380591.004.png 808380591.005.png 808380591.006.png 808380591.007.png 808380591.008.png 808380591.009.png
 
808380591.010.png 808380591.011.png 808380591.012.png 808380591.013.png 808380591.014.png 808380591.015.png 808380591.016.png
HALLUCINOGENIC DRUGS
AND
THEIR PSYCHOTHERAPEUTIC USE
THE PROCEEDINGS OF THE QUARTERLY MEETING
OF THE
ROYAL MEDICO-PSYCHOLOGICAL ASSOCIATION
IN LONDON
FEBRUARY 1961
Joint Editors:
RICHARD CROCKET, R. A. SANDISON,
AND ALEXANDER WALK
First of
arts
Without
thy
light
All the
rest
Would
sink in
night
FOUNDED
1844
MEDICA
TYPOGRAPHIA
LONDON
808380591.017.png
First Published 1963
©
ROYAL MEDICO-PSYCHOLOGICAL ASSOCIATION
1963
This book is copyright
It may not be reproduced by any means,
in whole or in part, without permission.
Applications with regard to copyright
should be addressed to the publishers
808380591.018.png 808380591.019.png
INTRODUCTION
ONE of the problems facing the organisers of a psychiatric conference is that the
theme is seldom sufficiently compact to permit the printed proceedings being
read easily and smoothly. The theme of the conference which is reported in this
monograph attracted a large number of speakers from several disciplines, and al-
though these speakers confined themselves to the general topic of the hallucino-
genic drugs the discussion ranged to and fro over a wide area of investigation and
knowledge. The editors therefore offer this brief introduction which may serve to
help the reader to understand the ways in which the conference represented an
advance in knowledge in a field of psychiatry which is relatively new and only
The general properties of the older hallucinogenic drugs have been known
for centuries, but medical interest in them is less than a hundred years old. It is
less than twenty years since the hallucinogenic action of one of the more potent
synthetic compounds, LSD, was discovered by Hofmann. Some ten years later,
LSD was first used in an exploratory manner in the field of psychotherapy, on
the grounds that the subjective experiences of those normal subjects who had
volunteered to take LSD were similar in content to the unconscious material
produced by patients during analytical work. Early investigators in the realm of
psychotherapy found that regression to childhood occurred under LSD, with
recovery of lost or repressed memories of childhood. Following early reports of
success in psychotherapy in 1953 and 1954 in England, the U. S. A. and Germany,
a number of investigators started using LSD in an attempt to effect a cure in in-
tractable neurosis and to shorten the treatment time in others. In 1955 the clinical
application of LSD had made sufficient progress for the subject to find a place in
the programme of the Annual Meeting of the American Psychiatric Association
held in that year in Atlantic City. During the next four years individual papers
and communications to meetings and conferences came from clinicians and
other research workers from several European countries, and from Canada, the
United States and South America, whilst at the same time interest in LSD as a
possible therapeutic tool was becoming world-wide. By 1959 the prospect that
the hallucinogenic drugs were to have a profound influence in modifying existing
methods of psychotherapy found expression in a three day Macy Foundation
Conference on "The Use of LSD in Psychotherapy". The success of this en-
deavour encouraged workers in Europe to meet and to arrange their own dis-
cussions. The result was a small European symposium held at Göttingen in 1960,
followed by the more ambitious R. M. P. A. Conference in February 1961 which
forms the material of this monograph.
Research into the properties and potentialities of LSD and related com-
pounds has been intense since 1943, and consequently its application has
attracted the attention of neurophysiologists, pharmacologists, psychologists
and other research workers as well as of clinical psychiatrists. The findings in
808380591.020.png 808380591.021.png
INTRODUCTION
It was therefore the intention and hope of the organizers of the 1961
Conference in London that investigators from fields other than the clinical and
psychotherapeutic ones would be able to assist in interpreting the meaning of the
remarkable psychic changes accompanying the administration of the hallucino-
gens. Thus understood, the significance of the first Conference session becomes
clearer, with Dr. Cerletti orientating the meeting into the relationship of hallu-
cinogens to other, both naturally occurring and synthetic, chemical substances.
He indicated the importance of the chemical similarities and differences between
the known compounds, as far as they are known. The remaining speakers in the
opening session, drawn from the fields of experimental medicine and pharma-
cology, succeeded in establishing that some system which normally holds
together and integrates mental functioning is temporarily gravely impaired after
the administration of hallucinogens. This system may be identified as the ego
by the psychologist or the reticular arousal system by the neurophysiologist,
and the significance of this finding is not only of great importance to the
psychotherapist, but also offers a way of understanding between clinicians and
research workers.
As the conference settled down to discuss the clinical applications of the
hallucinogenic drugs, less emphasis was placed on their property of producing
visual and other hallucinations and more on their ability to loosen and disin-
tegrate ego function. This emphasis had led at Göttingen to the adoption by the
psychotherapists of the term 'psycholytic' as more appropriately describing what
happens to patients in this therapy. In this connection the long-standing
discussion as to whether the psycholytic drugs are psychotomimetic was
re-opened and Professor Martin Roth in his discussion of the papers of the
second session drew attention to the fact that it is the affective changes which
are more noticeable after the administration of LSD and that these should be
stressed rather than any comparison with the schizophrenic states.
Several speakers discussed the types of case most suitable for LSD therapy,
and there seemed some general agreement that tension states, phobic and ob-
sessive neurosis, sexual disorders and psychopathic conditions form the bulk
of cases successfully treated. Furthermore there was some agreement among
speakers that the revival of emotionally charged memories of childhood as well
as various abreactive phenomena, including acting-out, were important aspects
of treatment. The significance of transference relationships and of suggestion led
on to important contributions in the field of 'brain-washing' and hypnosis. In
view of the emotional content of the subject, the reader must draw his own
conclusions about the extent to which therapy with the psycholytics is related
to 'brain-washing'. At times it became clear that one of the difficulties in the
use of LSD arose from the therapist's very enthusiasm and affective identification
with the treatment situation. This state of affairs drew comment from the
analysts, whose role in the conference was that of devil's advocates rather than
that of disciples to the psycholytic therapists.
That the analysts should display reserve in relation to LSD therapy
became apparent when speakers described their methodology—frequently so
opposed to the traditional methods of psychoanalysis. Thus, speakers insisted on
the importance of a group atmosphere and of free communication between
808380591.022.png
Zgłoś jeśli naruszono regulamin